LOGIN TO YOUR ACCOUNT

Username
Password
Remember Me
Or use your Academic/Social account:

CREATE AN ACCOUNT

Or use your Academic/Social account:

Congratulations!

You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.

Important!

Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message

CREATE AN ACCOUNT

Name:
Username:
Password:
Verify Password:
E-mail:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Mehrotra, Rajnish; Devuyst, Olivier; Davies, Simon J.; Johnson, David W. (2016)
Publisher: American Society of Nephrology
Languages: English
Types: Article
Subjects: RC870, Up Front Matters
Technical innovations in peritoneal dialysis (PD), now used widely for the long-term treatment of ESRD, have significantly reduced therapy-related complications, allowing patients to be maintained on PD for longer periods. Indeed, the survival rate for patients treated with PD is now equivalent to that with in-center hemodialysis. In parallel, changes in public policy have spurred an unprecedented expansion in the use of PD in many parts of the world. Meanwhile, our improved understanding of the molecular mechanisms involved in solute and water transport across the peritoneum and of the pathobiology of structural and functional changes in the peritoneum with long-term PD has provided new targets for improving efficiency and for intervention. As with hemodialysis, almost half of all deaths on PD occur because of cardiovascular events, and there is great interest in identifying modality-specific factors contributing to these events. Notably, tremendous progress has been made in developing interventions that substantially reduce the risk of PD-related peritonitis. Yet the gains have been unequal among individual centers, primarily because of unequal clinical application of knowledge gained from research. The work to date has further highlighted the areas in need of innovation as we continue to strive to improve the health and outcomes of patients treated with PD.
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • 1. Ganter G: Uber die Beseitigung giftiger Stoffe aus dem Blute durch Dialyse. Munch Med Wochenschr, 70: 147-1481, 1923.
    • 2. Wear JB, Sisk IR, Trinkle AJ: Peritoneal lavage in the treatment of uremia: an experimental and clinical study. J Urol, 39: 53-62, 1938.
    • 3. Frank HA, Seligman AM, Fine J: Treatment of uremia after acute renal failure by peritoneal irrigation. JAMA : the journal of the American Medical Association, 130: 703- 705, 1946.
    • 4. Seligman AM, Frank HA, Fine J: Treatment of Experimental Uremia by Means of Peritoneal Irrigation. The Journal of clinical investigation, 25: 211-219, 1946.
    • 5. Frank HA, Seligman AM, Fine J: Further experiences with peritoneal irrigation for acuter renal failure including a description of modifications in method. Annals of surgery, 128: 561-608, 1948.
    • 6. Odel HM, Ferris DO, Power MH: Peritoneal lavage as an effective means of extrarenal excretion; a clinical appraisal. The American journal of medicine, 9: 63-77, 1950.
    • 7. Grollman A, Turner LB, Mc LJ: Intermittent peritoneal lavage in nephrectomized dogs and its application to the human being. AMA archives of internal medicine, 87: 379-390, 1951.
    • 8. Doolan PD, Murphy WP, Jr., Wiggins RA, Carter NW, Cooper WC, Watten RH, Alpen EL: An evaluation of intermittent peritoneal lavage. The American journal of medicine, 26: 831-844, 1959.
    • 9. Maxwell MH, Rockney RE, Kleeman CR, Twiss MR: Peritoneal dialysis. 1. Technique and applications. Journal of the American Medical Association, 170: 917-924, 1959.
    • 10. Boen ST, Mulinari AS, Dillard DH, Scribner BH: Periodic peritoneal dialysis in the management of chronic uremia. Transactions - American Society for Artificial Internal Organs, 8: 256-262, 1962.
    • 11. Tenckhoff H, Schechter H: A bacteriologically safe peritoneal access device. Transactions - American Society for Artificial Internal Organs, 14: 181-187, 1968.
    • 12. Popovich RP, Moncrief JW, Decherd JB, Bomar JB, Pyle WK: The definition of a novel portable/wearable equilibrium peritoneal dialysis technique. Transactions - American Society for Artificial Internal Organs, 5: 484-489, 1976.
    • 13. Oreopoulos DG, Robson M, Izatt S, Clayton S, deVeber GA: A simple and safe technique for continuous ambulatory peritoneal dialysis (CAPD). Transactions - American Society for Artificial Internal Organs, 24: 484-489, 1978.
    • 14. Maiorca R, Cantaluppi A, Cancarini GC, Scalamogna A, Broccoli R, Graziani G, Brasa S, Ponticelli C: Prospective controlled trial of a Y-connector and disinfectant to prevent peritonitis in continuous ambulatory peritoneal dialysis. Lancet, 2: 642-644, 1983.
    • 15. Buoncristiani U: Birth and evolution of the "Y" set. ASAIO J, 42: 8-11, 1996.
    • 16. Diaz-Buxo JA, Farmer CD, Walker PJ, Chandler JT, Holt KL: Continuous cyclic peritoneal dialysis: a preliminary report. Artificial organs, 5: 157-161, 1981.
    • 17. Ahmad S, Gallagher N, Shen F: Intermittent peritoneal dialysis: status reassessed. Transactions - American Society for Artificial Internal Organs, 25: 86-89, 1979.
    • 18. Heimburger O, Waniewski J, Werynski A, Tranaeus A, Lindholm B: Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity. Kidney international, 38: 495-506, 1990.
    • 19. Bloembergen WE, Port FK, Mauger EA, Wolfe RA: A comparison of mortality between patients treated with hemodialysis and peritoneal dialysis. Journal of the American Society of Nephrology : JASN, 6: 177-183, 1995.
    • 20. Mehrotra R: Peritoneal dialysis penetration in the United States: march toward the fringes? Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 26: 419-422, 2006. predictors, prognostic significance and effects of risk factor modification. Nephrology (Carlton), 12: 391-398, 2007.
    • 112. Jiang N, Qian J, Lin A, Lindholm B, Axelsson J, Yao Q: Initiation of glucose-based peritoneal dialysis is associated with increased prevalence of metabolic syndrome in nondiabetic patients with end-stage renal disease. Blood purification, 26: 423-428, 2008.
    • 113. Szeto CC, Chow KM, Kwan BC, Chung KY, Leung CB, Li PK: New-onset hyperglycemia in nondiabetic chinese patients started on peritoneal dialysis. American journal of kidney diseases : the official journal of the National Kidney Foundation, 49: 524-532, 2007.
    • 114. Choi SJ, Kim NR, Hong SA, Lee WB, Park MY, Kim JK, Hwang SD, Lee HK: Changes in body fat mass in patients after starting peritoneal dialysis. Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 31: 67-73, 2011.
    • 115. Lievense H, Kalantar-Zadeh K, Lukowsky LR, Molnar MZ, Duong U, Nissenson A, Krishnan M, Krediet R, Mehrotra R: Relationship of body size and initial dialysis modality on subsequent transplantation, mortality and weight gain of ESRD patients. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 27: 3631-3638, 2012.
    • 116. Ahmadi SF, Zahmatkesh G, Streja E, Mehrotra R, Rhee CM, Kovesdy CP, Gillen DL, Ahmadi E, Fonarow GC, Kalantar-Zadeh K: Association of Body Mass Index with Mortality in Peritoneal Dialysis Patients: A Systematic Review and Meta-Analysis. Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 2015.
    • 117. Bergstrom J, Furst P, Alvestrand A, Lindholm B: Protein and energy intake, nitrogen balance and nitrogen losses in patients treated with continuous ambulatory peritoneal dialysis. Kidney international, 44: 1048-1057, 1993.
    • 118. Park J, Ahmadi SF, Streja E, Molnar MZ, Flegal KM, Gillen D, Kovesdy CP, KalantarZadeh K: Obesity paradox in end-stage kidney disease patients. Progress in cardiovascular diseases, 56: 415-425, 2014.
    • 119. McDonald SP, Collins JF, Johnson DW: Obesity is associated with worse peritoneal dialysis outcomes in the Australia and New Zealand patient populations. Journal of the American Society of Nephrology : JASN, 14: 2894-2901, 2003.
    • 120. Fernandes NM, Bastos MG, Franco MR, Chaoubah A, Lima Mda G, Divino-Filho JC, Qureshi AR: Body size and longitudinal body weight changes do not increase mortality in incident peritoneal dialysis patients of the Brazilian peritoneal dialysis multicenter study. Clinics (Sao Paulo), 68: 51-58, 2013.
    • 121. Badve SV, Paul SK, Klein K, Clayton PA, Hawley CM, Brown FG, Boudville N, Polkinghorne KR, McDonald SP, Johnson DW: The association between body mass index and mortality in incident dialysis patients. PloS one, 9: e114897, 2014.
    • 122. Liao CT, Kao TW, Chou YH, Wu MS, Chen YM, Chuang HF, Hung KY, Chu TS, Wu KD, Tsai TJ: Associations of metabolic syndrome and its components with cardiovascular outcomes among non-diabetic patients undergoing maintenance peritoneal dialysis. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 26: 4047-4054, 2011.
    • 123. Szeto CC, Kwan BC, Chow KM, Leung CB, Cheng MS, Law MC, Li PK: Metabolic syndrome in peritoneal dialysis patients: choice of diagnostic criteria and prognostic implications. Clinical journal of the American Society of Nephrology : CJASN, 9: 779- 787, 2014.
    • 124. Chou CY, Liang CC, Kuo HL, Chang CT, Liu JH, Lin HH, Wang IK, Yang YF, Huang CC: Comparing risk of new onset diabetes mellitus in chronic kidney disease patients receiving peritoneal dialysis and hemodialysis using propensity score matching. PloS one, 9: e87891, 2014.
    • 125. Woodward RS, Schnitzler MA, Baty J, Lowell JA, Lopez-Rocafort L, Haider S, Woodworth TG, Brennan DC: Incidence and cost of new onset diabetes mellitus among U.S. wait-listed and transplanted renal allograft recipients. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 3: 590-598, 2003.
    • 126. Davies SJ, Woodrow G, Donovan K, Plum J, Williams P, Johansson AC, Bosselmann HP, Heimburger O, Simonsen O, Davenport A, Tranaeus A, Divino Filho JC: Icodextrin improves the fluid status of peritoneal dialysis patients: results of a double-blind randomized controlled trial. Journal of the American Society of Nephrology : JASN, 14: 2338-2344, 2003.
    • 127. Wolfson M, Piraino B, Hamburger RJ, Morton AR: A randomized controlled trial to evaluate the efficacy and safety of icodextrin in peritoneal dialysis. American journal of kidney diseases : the official journal of the National Kidney Foundation, 40: 1055-1065, 2002.
    • 128. de Moraes TP, Andreoli MC, Canziani ME, da Silva DR, Caramori JC, Ponce D, Cassi HV, de Andrade Bastos K, Rio DR, Pinto SW, Filho SR, de Campos LG, Olandoski M, Divino-Filho JC, Pecoits-Filho R: Icodextrin reduces insulin resistance in non-diabetic patients undergoing automated peritoneal dialysis: results of a randomized controlled trial (STARCH). Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 30: 1905-1911, 2015.
    • 129. Paniagua R, Ventura MD, Avila-Diaz M, Cisneros A, Vicente-Martinez M, Furlong MD, Garcia-Gonzalez Z, Villanueva D, Orihuela O, Prado-Uribe MD, Alcantara G, Amato D: Icodextrin improves metabolic and fluid management in high and high-average transport diabetic patients. Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 29: 422-432, 2009.
    • 130. Li PK, Culleton BF, Ariza A, Do JY, Johnson DW, Sanabria M, Shockley TR, Story K, Vatazin A, Verrelli M, Yu AW, Bargman JM: Randomized, controlled trial of glucosesparing peritoneal dialysis in diabetic patients. Journal of the American Society of Nephrology : JASN, 24: 1889-1900, 2013.
    • 131. Sniderman AD, Sloand JA, Li PK, Story K, Bargman JM: Influence of low-glucose peritoneal dialysis on serum lipids and apolipoproteins in the IMPENDIA/EDEN trials. Journal of clinical lipidology, 8: 441-447, 2014.
    • 132. Duong U, Mehrotra R, Molnar MZ, Noori N, Kovesdy CP, Nissenson AR, KalantarZadeh K: Glycemic control and survival in peritoneal dialysis patients with diabetes mellitus. Clinical journal of the American Society of Nephrology : CJASN, 6: 1041-1048, 2011.
    • 133. Yoo DE, Park JT, Oh HJ, Kim SJ, Lee MJ, Shin DH, Han SH, Yoo TH, Choi KH, Kang SW: Good glycemic control is associated with better survival in diabetic patients on peritoneal dialysis: a prospective observational study. PloS one, 7: e30072, 2012.
    • 134. Palmer SC, Navaneethan SD, Craig JC, Johnson DW, Perkovic V, Nigwekar SU, Hegbrant J, Strippoli GF: HMG CoA reductase inhibitors (statins) for dialysis patients. The Cochrane database of systematic reviews, 9: CD004289, 2013.
    • 135. Baigent C, Landray MJ, Reith C, Emberson J, Wheeler DC, Tomson C, Wanner C, Krane V, Cass A, Craig J, Neal B, Jiang L, Hooi LS, Levin A, Agodoa L, Gaziano M, Kasiske B, Walker R, Massy ZA, Feldt-Rasmussen B, Krairittichai U, Ophascharoensuk V, Fellstrom B, Holdaas H, Tesar V, Wiecek A, Grobbee D, de Zeeuw D, GronhagenRiska C, Dasgupta T, Lewis D, Herrington W, Mafham M, Majoni W, Wallendszus K, Grimm R, Pedersen T, Tobert J, Armitage J, Baxter A, Bray C, Chen Y, Chen Z, Hill M, Knott C, Parish S, Simpson D, Sleight P, Young A, Collins R: The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. Lancet, 377: 2181-2192, 2011.
    • 136. Bargman JM, Thorpe KE, Churchill DN: Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study. Journal of the American Society of Nephrology : JASN, 12: 2158-2162, 2001.
    • 137. Termorshuizen F, Dekker FW, van Manen JG, Korevaar JC, Boeschoten EW, Krediet RT: Relative contribution of residual renal function and different measures of adequacy to survival in hemodialysis patients: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2. Journal of the American Society of Nephrology : JASN, 15: 1061-1070, 2004.
    • 138. Fernandez-Lucas M, Teruel-Briones JL, Gomis-Couto A, Villacorta-Perez J, QueredaRodriguez-Navarro C: Maintaining residual renal function in patients on haemodialysis: 5- year experience using a progressively increasing dialysis regimen. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 32: 767-776, 2012.
    • 139. Lin YF, Huang JW, Wu MS, Chu TS, Lin SL, Chen YM, Tsai TJ, Wu KD: Comparison of residual renal function in patients undergoing twice-weekly versus three-times-weekly haemodialysis. Nephrology (Carlton), 14: 59-64, 2009.
    • 140. Seo EY, An SH, Cho JH, Suh HS, Park SH, Gwak H, Kim YL, Ha H: Effect of biocompatible peritoneal dialysis solution on residual renal function: a systematic review of randomized controlled trials. Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 34: 724-731, 2014.
    • 141. Kjaergaard KD, Peters CD, Jespersen B, Tietze IN, Madsen JK, Pedersen BB, Novosel MK, Laursen KS, Bibby BM, Strandhave C, Jensen JD: Angiotensin blockade and progressive loss of kidney function in hemodialysis patients: a randomized controlled trial. American journal of kidney diseases : the official journal of the National Kidney Foundation, 64: 892-901, 2014.
    • 142. Jansen MA, Hart AA, Korevaar JC, Dekker FW, Boeschoten EW, Krediet RT: Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney international, 62: 1046-1053, 2002.
    • 143. Moist LM, Port FK, Orzol SM, Young EW, Ostbye T, Wolfe RA, Hulbert-Shearon T, Jones CA, Bloembergen WE: Predictors of loss of residual renal function among new dialysis patients. Journal of the American Society of Nephrology : JASN, 11: 556-564, 2000.
    • 144. van Biesen W, Claes K, Covic A, Fan S, Lichodziejewska-Niemierko M, Schoder V, Verger C, Wabel P: A multicentric, international matched pair analysis of body composition in peritoneal dialysis versus haemodialysis patients. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 28: 2620-2628, 2013.
    • 145. Ha IS, Yap HK, Munarriz RL, Zambrano PH, Flynn JT, Bilge I, Szczepanska M, Lai WM, Antonio ZL, Gulati A, Hooman N, van Hoeck K, Higuita LM, Verrina E, Klaus G, Fischbach M, Riyami MA, Sahpazova E, Sander A, Warady BA, Schaefer F: Risk factors for loss of residual renal function in children treated with chronic peritoneal dialysis. Kidney international, 88: 605-613, 2015.
    • 146. Medcalf JF, Harris KP, Walls J: Role of diuretics in the preservation of residual renal function in patients on continuous ambulatory peritoneal dialysis. Kidney international, 59: 1128-1133, 2001.
    • 147. Johnson DW, Brown FG, Clarke M, Boudville N, Elias TJ, Foo MW, Jones B, Kulkarni H, Langham R, Ranganathan D, Schollum J, Suranyi M, Tan SH, Voss D: Effects of biocompatible versus standard fluid on peritoneal dialysis outcomes. Journal of the American Society of Nephrology : JASN, 23: 1097-1107, 2012.
    • 148. Cho Y, Johnson DW, Craig JC, Strippoli GF, Badve SV, Wiggins KJ: Biocompatible dialysis fluids for peritoneal dialysis. The Cochrane database of systematic reviews, 3: CD007554, 2014.
    • 149. Udayaraj UP, Steenkamp R, Caskey FJ, Rogers C, Nitsch D, Ansell D, Tomson CR: Blood pressure and mortality risk on peritoneal dialysis. American journal of kidney diseases : the official journal of the National Kidney Foundation, 53: 70-78, 2009.
    • 150. Davies SJ, Davenport A: The role of bioimpedance and biomarkers in helping to aid clinical decision-making of volume assessments in dialysis patients. Kidney international, 86: 489-496, 2014.
    • 151. Brown EA, Davies SJ, Rutherford P, Meeus F, Borras M, Riegel W, Divino Filho JC, Vonesh E, van Bree M: Survival of functionally anuric patients on automated peritoneal dialysis: the European APD Outcome Study. Journal of the American Society of Nephrology : JASN, 14: 2948-2957, 2003.
    • 152. Jansen MA, Termorshuizen F, Korevaar JC, Dekker FW, Boeschoten E, Krediet RT: Predictors of survival in anuric peritoneal dialysis patients. Kidney international, 68: 1199-1205, 2005.
    • 153. Johnson DW, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, Bannister KM, Badve SV: Superior survival of high transporters treated with automated versus continuous ambulatory peritoneal dialysis. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 25: 1973-1979, 2010.
    • 154. Cho Y, Johnson DW, Badve S, Craig JC, Strippoli GF, Wiggins KJ: Impact of icodextrin on clinical outcomes in peritoneal dialysis: a systematic review of randomized controlled trials. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 28: 1899- 1907, 2013.
    • 155. Mehrotra R, Duong U, Jiwakanon S, Kovesdy CP, Moran J, Kopple JD, Kalantar-Zadeh K: Serum albumin as a predictor of mortality in peritoneal dialysis: comparisons with hemodialysis. American journal of kidney diseases : the official journal of the National Kidney Foundation, 58: 418-428, 2011.
    • 156. John B, Tan BK, Dainty S, Spanel P, Smith D, Davies SJ: Plasma volume, albumin, and fluid status in peritoneal dialysis patients. Clinical journal of the American Society of Nephrology : CJASN, 5: 1463-1470, 2010.
    • 157. Tan BK, Yu Z, Fang W, Lin A, Ni Z, Qian J, Woodrow G, Jenkins SB, Wilkie ME, Davies SJ: Longitudinal bioimpedance vector plots add little value to fluid management of peritoneal dialysis patients. Kidney international, 2015.
    • 158. Cho Y, Johnson DW: Peritoneal dialysis-related peritonitis: towards improving evidence, practices, and outcomes. American journal of kidney diseases : the official journal of the National Kidney Foundation, 64: 278-289, 2014.
    • 159. Johnson DW, Dent H, Hawley CM, McDonald SP, Rosman JB, Brown FG, Bannister KM, Wiggins KJ: Associations of dialysis modality and infectious mortality in incident dialysis patients in Australia and New Zealand. American journal of kidney diseases : the official journal of the National Kidney Foundation, 53: 290-297, 2009.
    • 160. Szeto CC, Wong TY, Chow KM, Leung CB, Li PK: The clinical course of culturenegative peritonitis complicating peritoneal dialysis. American journal of kidney diseases : the official journal of the National Kidney Foundation, 42: 567-574, 2003.
    • 161. Szeto CC, Chow KM, Kwan BC, Law MC, Chung KY, Yu S, Leung CB, Li PK: Staphylococcus aureus peritonitis complicates peritoneal dialysis: review of 245 consecutive cases. Clinical journal of the American Society of Nephrology : CJASN, 2: 245-251, 2007.
    • 162. Szeto CC, Kwan BC, Chow KM, Lau MF, Law MC, Chung KY, Leung CB, Li PK: Coagulase negative staphylococcal peritonitis in peritoneal dialysis patients: review of 232 consecutive cases. Clinical journal of the American Society of Nephrology : CJASN, 3: 91- 97, 2008.
    • 163. Barraclough K, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, Bannister KM, Johnson DW: Corynebacterium peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 82 cases. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 24: 3834-3839, 2009.
    • 164. Fahim M, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, Bannister KM, Johnson DW: Culture-negative peritonitis in peritoneal dialysis patients in Australia: predictors, treatment, and outcomes in 435 cases. American journal of kidney diseases : the official journal of the National Kidney Foundation, 55: 690-697, 2010.
    • 165. Miles R, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, Bannister KM, Johnson DW: Predictors and outcomes of fungal peritonitis in peritoneal dialysis patients. Kidney international, 76: 622-628, 2009.
    • 166. Barraclough K, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, Bannister KM, Johnson DW: Polymicrobial peritonitis in peritoneal dialysis patients in Australia: predictors, treatment, and outcomes. American journal of kidney diseases : the official journal of the National Kidney Foundation, 55: 121-131, 2010.
    • 167. Edey M, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, Bannister KM, Johnson DW: Enterococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 116 cases. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 25: 1272-1278, 2010.
    • 168. Fahim M, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, Bannister KM, Johnson DW: Coagulase-negative staphylococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 936 cases. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 25: 3386-3392, 2010.
    • 169. Govindarajulu S, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, Bannister KM, Johnson DW: Staphylococcus aureus peritonitis in Australian peritoneal dialysis patients: predictors, treatment, and outcomes in 503 cases. Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 30: 311-319, 2010.
    • 170. Jarvis EM, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, Bannister KM, Johnson DW: Predictors, treatment, and outcomes of non-Pseudomonas Gramnegative peritonitis. Kidney international, 78: 408-414, 2010.
    • 171. Ghali JR, Bannister KM, Brown FG, Rosman JB, Wiggins KJ, Johnson DW, McDonald SP: Microbiology and outcomes of peritonitis in Australian peritoneal dialysis patients. Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 31: 651-662, 2011.
    • 172. Brown MC, Simpson K, Kerssens JJ, Mactier RA: Encapsulating peritoneal sclerosis in the new millennium: a national cohort study. Clinical journal of the American Society of Nephrology : CJASN, 4: 1222-1229, 2009.
    • 173. Johnson DW, Cho Y, Livingston BE, Hawley CM, McDonald SP, Brown FG, Rosman JB, Bannister KM, Wiggins KJ: Encapsulating peritoneal sclerosis: incidence, predictors, and outcomes. Kidney international, 77: 904-912, 2010.
    • 174. Howard K, Hayes A, Cho Y, Cass A, Clarke M, Johnson DW: Economic evaluation of neutral-pH, low-glucose degradation product peritoneal dialysis solutions compared with standard solutions: a secondary analysis of the balANZ Trial. American journal of kidney diseases : the official journal of the National Kidney Foundation, 65: 773-779, 2015.
    • 175. Morton RL, Snelling P, Webster AC, Rose J, Masterson R, Johnson DW, Howard K: Dialysis modality preference of patients with CKD and family caregivers: a discretechoice study. American journal of kidney diseases : the official journal of the National Kidney Foundation, 60: 102-111, 2012.
    • 176. Campbell DJ, Johnson DW, Mudge DW, Gallagher MP, Craig JC: Prevention of peritoneal dialysis-related infections. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 30: 1461-1472, 2015.
    • 177. Huang JW, Hung KY, Yen CJ, Wu KD, Tsai TJ: Comparison of infectious complications in peritoneal dialysis patients using either a twin-bag system or automated peritoneal dialysis. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 16: 604- 607, 2001.
    • 178. Han SH, Lee SC, Ahn SV, Lee JE, Choi HY, Kim BS, Kang SW, Choi KH, Han DS, Lee HY: Improving outcome of CAPD: twenty-five years' experience in a single Korean center. Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 27: 432-440, 2007.
    • 179. Moraes TP, Pecoits-Filho R, Ribeiro SC, Rigo M, Silva MM, Teixeira PS, Pasqual DD, Fuerbringer R, Riella MC: Peritoneal dialysis in Brazil: twenty-five years of experience in a single center. Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 29: 492-498, 2009.
    • 180. Huang ST, Chuang YW, Cheng CH, Wu MJ, Chen CH, Yu TM, Shu KH: Evolution of microbiological trends and treatment outcomes in peritoneal dialysis-related peritonitis. Clinical nephrology, 75: 416-425, 2011.
    • 181. Rocha A, Rodrigues A, Teixeira L, Carvalho MJ, Mendonca D, Cabrita A: Temporal trends in peritonitis rates, microbiology and outcomes: the major clinical complication of peritoneal dialysis. Blood purification, 33: 284-291, 2012.
    • 182. Ozisik L, Ozdemir FN, Tanriover MD: The changing trends of peritoneal dialysis related peritonitis and novel risk factors. Renal failure, 37: 1027-1032, 2015.
    • 183. Kiernan L, Kliger A, Gorban-Brennan N, Juergensen P, Tesin D, Vonesh E, Finkelstein F: Comparison of continuous ambulatory peritoneal dialysis-related infections with different "Y-tubing" exchange systems. Journal of the American Society of Nephrology : JASN, 5: 1835-1838, 1995.
    • 184. Lo WK, Chan CY, Cheng SW, Poon JF, Chan DT, Cheng IK: A prospective randomized control study of oral nystatin prophylaxis for Candida peritonitis complicating continuous ambulatory peritoneal dialysis. American journal of kidney diseases : the official journal of the National Kidney Foundation, 28: 549-552, 1996.
    • 185. Thodis E, Bhaskaran S, Pasadakis P, Bargman JM, Vas SI, Oreopoulos DG: Decrease in Staphylococcus aureus exit-site infections and peritonitis in CAPD patients by local application of mupirocin ointment at the catheter exit site. Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 18: 261-270, 1998.
    • 186. Bernardini J, Bender F, Florio T, Sloand J, Palmmontalbano L, Fried L, Piraino B: Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients. Journal of the American Society of Nephrology : JASN, 16: 539-545, 2005.
    • 187. Troidle L, Finkelstein F: Treatment and outcome of CPD-associated peritonitis. Annals of clinical microbiology and antimicrobials, 5: 6, 2006.
    • 188. Gadola L, Poggi C, Poggio M, Saez L, Ferrari A, Romero J, Fumero S, Ghelfi G, Chifflet L, Borges PL: Using a multidisciplinary training program to reduce peritonitis in peritoneal dialysis patients. Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 33: 38-45, 2013.
    • 189. Zhang L, Hawley CM, Johnson DW: Focus on peritonea dialysis training: working to decrease peritonitis rates. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association: in press, 2015.
    • 190. Schaepe C, Bergjan M: Educational interventions in peritoneal dialysis: a narrative review of the literature. International journal of nursing studies, 52: 882-898, 2015.
    • 191. ANZDATA Registry: 37th Report, Chapter 5: Peritoneal Dialysis, Australia and New Zealand Dialysis and Transplant Registry. Adelaide, Australia, 2015.
    • 192. Jose MD, Johnson DW, Mudge DW, Tranaeus A, Voss D, Walker R, Bannister KM: Peritoneal dialysis practice in Australia and New Zealand: a call to action. Nephrology (Carlton), 16: 19-29, 2011.
    • 193. Johnson DW, Badve SV, Pascoe EM, Beller E, Cass A, Clark C, de Zoysa J, Isbel NM, McTaggart S, Morrish AT, Playford EG, Scaria A, Snelling P, Vergara LA, Hawley CM: Antibacterial honey for the prevention of peritoneal-dialysis-related infections (HONEYPOT): a randomised trial. The Lancet Infectious diseases, 14: 23-30, 2014.
    • 194. Campbell DJ, Brown F, Craig J, Gallagher M, Johnson DW, Kirkland G, Kumar SK, Lim WH, Ranganathan D, Saweirs W, Sud K, Toussaint ND, Walker RG, Yehia M, Mudge DW: Assessment of current practice and barriers to antimicrobial prophylaxis in peritoneal dialysis patients. Nephrology (Carlton), 19: 42, 2014.
    • 195. Walker A, Bannister K, George C, Mudge D, Yehia M, Lonergan M, Chow J: KHACARI Guideline: peritonitis treatment and prophylaxis. Nephrology (Carlton), 19: 69-71, 2014.
    • 196. Zhang L, Badve SV, Pascoe EM, Beller E, Cass A, Clark C, De Zoysa J, Isbel NM, McTaggart S, Morrish AT, Playford EG, Scaria A, Snelling P, Vergara LA, Hawley CM, Johnson DW, Honeypot Study Collaborative: Microbiological results of the HONEYPOT study - secondary analysis of a randomised, controlled trial of exit site application of medihoney for the prevention of catheter-associated infections in PD patients. . Nephrology (Carlton), 19: 30, 2014.
    • 197. Piraino B, Bernardini J, Brown E, Figueiredo A, Johnson DW, Lye WC, Price V, Ramalakshmi S, Szeto CC: ISPD position statement on reducing the risks of peritoneal dialysis-related infections. Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 31: 614-630, 2011.
    • 198. Kopriva-Altfahrt G, Konig P, Mundle M, Prischl F, Roob JM, Wiesholzer M, Vychytil A, Arneitz K, Karner A, Artes R, Wolf E, Auinger M, Pawlak A, Fraberger J, Hofbauer S, Galvan G, Salmhofer H, Pichler B, Wazel M, Gruber M, Thonhofer A, Hager A, Malajner S, Heiss S, Braunsteiner T, Zweiffler M, Rudnicki M, Kogler R, Kohlhauser D, Wiesinger T, Moser E, Kotanko P, Loibner H, Nitz H, Miska HJ, Wenzel R, Wolfer M, Breuss H, Holzl B, Prischi F, Schmekal B, Riener EM, Wonisch W, Vikydal R, Frank B, Wieser C, Pokorny K: Exit-site care in Austrian peritoneal dialysis centers -- a nationwide survey. Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 29: 330-339, 2009.
    • 199. Kavanagh D, Prescott GJ, Mactier RA: Peritoneal dialysis-associated peritonitis in Scotland (1999-2002). Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 19: 2584- 2591, 2004.
    • 200. Davenport A: Peritonitis remains the major clinical complication of peritoneal dialysis: the London, UK, peritonitis audit 2002-2003. Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 29: 297-302, 2009.
    • 201. Martin LC, Caramori JC, Fernandes N, Divino-Filho JC, Pecoits-Filho R, Barretti P: Geographic and educational factors and risk of the first peritonitis episode in Brazilian Peritoneal Dialysis study (BRAZPD) patients. Clinical journal of the American Society of Nephrology : CJASN, 6: 1944-1951, 2011.
    • 202. Figueiredo AE, Moraes TP, Bernardini J, Poli-de-Figueiredo CE, Barretti P, Olandoski M, Pecoits-Filho R: Impact of patient training patterns on peritonitis rates in a large national cohort study. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 30: 137- 142, 2015.
    • 203. Badve SV, Smith A, Hawley CM, Johnson DW: Adherence to guideline recommendations for infection prophylaxis in peritoneal dialysis patients. NDT plus, 2: 508, 2009.
    • 204. Nadeau-Fredette AC, Johnson DW, Hawley CM, Pascoe E, Cho Y, Clayton PA, Borlace M, Badve SV, Sud K, Boudville N, McDonald SP: Centre-specific factors associated with
  • Inferred research data

    The results below are discovered through our pilot algorithms. Let us know how we are doing!

    Title Trust
    66
    66%
  • No similar publications.

Share - Bookmark

Funded by projects

  • NIH | Biological Determinants of ...

Cite this article